In parallel, loss of SMAD4, located at 18q21 or sometimes 14q22 depending on cytogenetic context, impairs TGF-β–mediated growth inhibition and is frequently observed in advanced adenomas or intramucosal carcinomas (26). Here, TGFB1 is linked to adenoma.